Product finder

T-Track® CMV

ELISpot assay for monitoring the functionality of the CMV-specific cell mediated immunity (CMI) in CMV-seropositive patients.
  1. /
  2. Products & Automation
  3. /
  4. Product finder

Mikrogen T-Track® CMV is a standardized, highly sensitive and reliable in vitro diagnostic test based on ELISpot technology. The CMV test is designed to identify patient populations at increased risk for CMV-related clinical complications and to improve individual CMV management. Using T-activation technology patented by Mikrogen (formerly Lophius Biosciences GmbH), T-Track® CMV detects IFN-γ secretion from the comprehensive network of clinically relevant CMV-reactive effector cells, allowing a semi-quantitative assessment of CMV-specific immunocompetence. The test is not suitable for the detection of acute CMV infection.

Products

T-Track® CMV
Reagents for the analysis of 12 patient samples
 Article no.: 11001003 Request

Advantages

  • To support antiviral therapy decisions, T-Track® CMV results can be collected and analyzed in diagnostic laboratories within 24 hours
  • Assessment of CMV-specific immune response and reconstitution
  • Measurement of CD8+, CD4+, and NK cell functionality, as well as NKT-like and antigen-presenting cells (APCs)
  • Optimized, user-friendly protocol
  • HLA-independent application
  • Evaluation with T-Track® CMV Calculator Software (part number: 11071001, free of charge) recommended

Safe and reliable

Highly sensitive and standardized instrument for immune monitoring

T-cell diagnostics

To support individual therapy decisions

High Standard

CE-marked IVD (in vitro diagnostic device)